Invasive Breast Cancer with HER2 ≥4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing

Invasive Breast Cancer with HER2 ≥4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing

Qianming Bai,1– 3,* Hong Lv,1– 3,* Longlong Bao,1– 3,* Yu Yang,1– 3 Xin Zhang,4 Heng Chang,1– 3 Tian Xue,1– 3 Min Ren,1– 3 Xiaoli Zhu,1– 3 Xiaoyan Zhou,1– 3,* Wentao Yang1– 3,* 1Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032...

Full description

Bibliographic Details
Main Authors: Bai Q, Lv H, Bao L, Yang Y, Zhang X, Chang H, Xue T, Ren M, Zhu X, Zhou X, Yang W
Format: Article
Language:English
Published: Dove Medical Press 2023-08-01
Series:Breast Cancer: Targets and Therapy
Subjects:
breast cancer
her2
fish
21-gene expression assay
mammaprint plus blueprint
Online Access:https://www.dovepress.com/invasive-breast-cancer-with-her2-40-and-60-risk-classification-and-mol-peer-reviewed-fulltext-article-BCTT

Internet

https://www.dovepress.com/invasive-breast-cancer-with-her2-40-and-60-risk-classification-and-mol-peer-reviewed-fulltext-article-BCTT

Similar Items